https://www.fiercebiotech.com/biotech/what-can-we-learn-2024s-biotech-ipos
Above audio provides some good insights on the market conditions and companies ability to raise money. Key points the speaker raises is oncology, compelling science and further along companies are in the clinical trials are the one's attracting funds.
2023 was a barren year so far as fund raising for biotech companies is concerned. 2024 changed that for better and 2025 will continue the trend.
A good listen, enjoy!!!!!!
spidey
https://www.fiercebiotech.com/biotech/what-can-we-learn-2024s-bio...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |